Miller Thomas F.
SEC insider (Form 3/4/5 filer). CIK 0002034921. Chief Executive Officer at Iambic Therapeutics, Inc. (IAM) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.
Companies Miller Thomas F. has filed insider reports for
- Iambic Therapeutics, Inc. (IAM): Director, Officer, Chief Executive Officer
- VERACYTE, INC. (VCYT): Director
Miller Thomas F.
CIK: 0002034921
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
